Brand name: Not yet established
Generic name: elvitegravir, or EVG
Class: Integrase inhibitor (integrase strand transfer inhibitor, or INSTI)
Manufacturer: Gilead Sciences, Inc., www.gilead.com, (800) GILEAD-5 (445-3235)
AWP: TBD; investigational drug at press time.
Standard Dose: One 150 mg or one 85 mg tablet once a day boosted with either Norvir or cobicistat. The dose depends on drug interactions with the co-administered PI. Take missed dose as soon as possible, unless it is closer in time to your next dose. Do not double up on your next dose.
Potential side effects and toxicity: Seen in clinical studies:View Full Article
ViiV Announces Expanded Access to Once-a-Day Integrase Inhibitor ... But Activists Are Concerned About Its Potential Misuse
Visit Positively Aware's website to find out more about the publication.
Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read TheBody.com's Comment Policy.)